Literature DB >> 27300033

Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.

Zehra Kucukaydın1, Cevdet Duran2, Mustafa Basaran1, Fatos Camlica3, Sami Said Erdem4, Ahmet Basaran1, Orkide Kutlu5, Ferda Sevimli Burnik6, Halis Elmas7, Mustafa Sait Gonen8.   

Abstract

PURPOSE: Insulin resistance (IR) and increased oxidative stress (OS) are the characteristics of polycystic ovary syndrome (PCOS). In this study, we aimed to evaluate the effects of oral glucose tolerance (OGTT) and mixed meal tests (MMT) on plasma total oxidant (TOS) and total antioxidant status (TAS) in patients with PCOS and the relationship between these parameters and IR, calculated via homeostasis of model assessment-IR (HOMA-IR) and Matsuda's insulin sensitivity index (ISI) derived from OGTT and MMT.
METHODS: Twenty-two patients with PCOS, and age- and body mass index (BMI)-matched 20 women as controls were enrolled into the study. Five-hour OGTT and MMT were performed on different days, and before and after these tests, plasma TOS and TAS levels were investigated. IR was calculated with HOMA-IR and Matsuda's ISI.
RESULTS: HOMA-IR levels were higher in patients with PCOS, compared to controls, while Matsuda's ISI derived from OGTT and MMT was higher in controls. Plasma TOS levels before OGTT and MMT were higher in patients with PCOS than controls, while TAS levels were similar. After OGTT, plasma TOS levels became decreased at 5th hour, when compared to baseline values in PCOS group. Likewise, the same decrement was found in controls, but the decrement was not significant. After OGTT and MMT at 5th hour, no changes were observed in TAS levels, compared to baseline.
CONCLUSION: Matsuda's ISIs derived from OGTT and MMT can be used instead of each other, and interestingly, we found a decrease in TOS levels after OGTT in patients with PCOS.

Entities:  

Keywords:  Insulin resistance; Mixed meal test; Oral glucose tolerance test; Polycystic ovary syndrome; Total antioxidant status; Total oxidant status

Mesh:

Substances:

Year:  2016        PMID: 27300033     DOI: 10.1007/s40618-016-0498-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  44 in total

1.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2004-04       Impact factor: 3.281

2.  The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.

Authors:  Y Çakıroğlu; F Vural; B Vural
Journal:  J Endocrinol Invest       Date:  2016-03-15       Impact factor: 4.256

3.  Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.

Authors:  A J Karter; E J Mayer-Davis; J V Selby; R B D'Agostino; S M Haffner; P Sholinsky; R Bergman; M F Saad; R F Hamman
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

4.  Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes.

Authors:  P Mohanty; W Hamouda; R Garg; A Aljada; H Ghanim; P Dandona
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects.

Authors:  Hadi Selimoglu; Cevdet Duran; Sinem Kiyici; Metin Guclu; Canan Ersoy; Guven Ozkaya; Erdinc Erturk; Ercan Tuncel; Sazi Imamoglu
Journal:  Endocrine       Date:  2009-07-14       Impact factor: 3.633

7.  Meal-generated oxidative stress in type 2 diabetic patients.

Authors:  A Ceriello; N Bortolotti; E Motz; A Crescentini; S Lizzio; A Russo; L Tonutti; C Taboga
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

8.  Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.

Authors:  S M Haffner; R D'Agostino; M F Saad; M Rewers; L Mykkänen; J Selby; G Howard; P J Savage; R F Hamman; L E Wagenknecht
Journal:  Diabetes       Date:  1996-06       Impact factor: 9.461

9.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

10.  Oxyradical Stress, Endocannabinoids, and Atherosclerosis.

Authors:  Anberitha T Matthews; Matthew K Ross
Journal:  Toxics       Date:  2015-12-03
View more
  5 in total

1.  Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.

Authors:  R M Ruggeri; M Cristani; T M Vicchio; A Alibrandi; S Giovinazzo; A Saija; A Campennì; F Trimarchi; S Gangemi
Journal:  J Endocrinol Invest       Date:  2018-05-23       Impact factor: 4.256

2.  Evaluation of serum hepcidin and iron levels in patients with PCOS: a case-control study.

Authors:  B Hossein Rashidi; S Shams; M Shariat; H Kazemi Jaliseh; M Mohebi; F Haghollahi
Journal:  J Endocrinol Invest       Date:  2017-03-08       Impact factor: 4.256

3.  Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Authors:  U Durmus; C Duran; S Ecirli
Journal:  J Endocrinol Invest       Date:  2016-11-12       Impact factor: 4.256

4.  Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.

Authors:  D Liao; H Yu; L Han; C Zhong; X Ran; D Wang; L Mo
Journal:  J Endocrinol Invest       Date:  2018-03-15       Impact factor: 4.256

5.  Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome.

Authors:  Sibel Sak; Hacer Uyanikoglu; Adnan Incebiyik; Hatice Incebiyik; Nese Gul Hilali; Tevfik Sabuncu; Erdal Sak
Journal:  Clin Exp Reprod Med       Date:  2018-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.